Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Octapharma and BioMatrix Specialty Pharmacy are supporting a new study focused on treating patients with COVID-19 and presenting with COVID-19-associated myocardial dysfunction.
read more
Thursday, February 16, 2012
Ockham, a leading, global full-service contract research organization (CRO) with a focus in oncology, today announces it has completed the acquisition of Nexus Oncology. The transaction also provides Ockham with an institutional investment partner.
read more
Friday, February 07, 2014
Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)
(“NW Bio”), a biotechnology company developing non-toxic DCVax® personalized immune
therapies for solid tumor cancers, announced today that Dr. Marnix Bosch, Chief Technical Officer of
NW Bio, will ...
read more
A novel ophthalmic solution from R-Tech Ueno (Tokyo, Japan) made using Novozymes Biopharma’s recombinant human albumin has recently obtained FDA approval to undergo Phase I/II clinical trials in the United States.
read more
Tuesday, January 10, 2023
Novotech an Asia Pacific centered biotech CRO announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group.
read more
Monday, November 15, 2021
Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and accelerate clinical development, today announces the opening of its US headquarters in Boston, Massachusetts as part of the company’s ...
read more
Thursday, January 17, 2013
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry today announced that Kristin Arnold, Ph.D. has joined the company as vice president, product development ...
read more
Tuesday, November 15, 2022
NorthStar Medical Radioisotopes announced a significant expansion of its business platform with the formation of a new, patient-focused Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) services unit.
read more
The National Institutes of Health has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease areas, including Alzheimer’s disease, ...
read more
Redwood Bioscience and Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the results of an in vivo toxicology study, ...
read more
Thursday, February 03, 2022
Nashville Biosciences and Datavant announced a collaboration that will enable biopharma companies to connect their trial data to research datasets from BioVU®. The linkages will accelerate drug discovery, clinical development, and drug safety ...
read more
MRO, a leading clinical data workflow platform and the KLAS-rated No. 1 provider of release of information (ROI) solutions, announced the acquisition of Rockford, IL-based FIGmd, a leading provider of clinical, claims and quality data acquisition ...
read more
MPI Research and Exemplar Genetics today announced the first successful validation of a new genetically engineered miniature pig model, offering an attractive alternative to rodent models, of atherosclerosis. The ExeGen® LDLR miniswine is a pig model...
read more
Friday, February 15, 2013
Metrics Inc. has added a new formulation scientist to its growing staff of pharmaceutical chemists.
read more
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per ...
read more